Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma.
Lukas AndereggenAngelo TortoraGerrit A SchubertChristian MusahlJanine FreyAndrea StiegerBéatrice KobelMarkus M LuediMichel RoethlisbergerLuigi MarianiJürgen BeckEmanuel ChristPublished in: Acta neurochirurgica (2024)
Correcting hyperprolactinemia and its associated hypogonadism significantly improves ED in the majority of men with prolactinomas over the long term, regardless of the primary treatment strategy employed. In addition to addressing endocrine deficiencies, the early initiation of weight control programs may be considered for men with lactotroph adenomas and ED. Although our study suggests an association between BMI and the risk of persistent ED, further research is needed to establish any causal relationships.